Pediatric chronic myeloid leukemia in myeloid blast crisis.
Biswajit DeyAnirban DuttaPublished in: Autopsy & case reports (2023)
Chronic myeloid leukemia (CML) accounts for 2-3% of childhood leukemias. About 5% of cases present in a blastic phase of CML which clinically and morphologically mimics more common acute leukemias of childhood. We report a case of a 3-year-old male who presented with gradual onset swelling of the abdomen and extremities along with generalized weakness. Examination revealed massive splenomegaly, pallor, and pedal edema. Initial workup showed anemia, thrombocytopenia, and leukocytosis (120,000/uL) with a blast percentage of 35%. Blasts were positive for CD13, CD33, CD117, CD34 and HLA-DR, and stained negative for Myeloperoxidase and Periodic Acid Schiff. Fluorescence in situ hybridization was positive for b3a2/e14a2 junction BCR-ABL1 transcript and negative for RUNX1-RUNX1T1/t(8;21), clinching the diagnosis of CML in myeloid blast crisis. The patient expired within 17 days of diagnosis and initiation of therapy.
Keyphrases
- chronic myeloid leukemia
- public health
- dendritic cells
- transcription factor
- acute myeloid leukemia
- bone marrow
- early life
- childhood cancer
- liver failure
- respiratory failure
- chronic kidney disease
- stem cells
- drug induced
- immune response
- rna seq
- young adults
- aortic dissection
- mechanical ventilation
- soft tissue
- energy transfer
- acute respiratory distress syndrome
- editorial comment